Rovalpituzumab tesirine

DB13017InvestigationalProtein Based Therapies

Rovalpituzumab Tesirine has been used in trials studying the treatment of GLIOBLASTOMA, Malignant Melanoma, Other Solid Tumors, Small Cell Lung Cancer, and Medullary Thyroid Cancer, among others.

Mechanism: Pharmacologically active on Delta-like protein 3
Curator reviewed

Resolves to

Compound

UNIIP256HB60FFCAS1613313-09-9

Targets

Q9NYJ7DLL3

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

382Drug interactionsStructured to mechanism, not free text

11Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Rovalpituzumab tesirine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account